Project B5(Jw Pharmaceutical Corp)

N/A

Report date: 2023/08/22 17:03:04
NME

Base Information

Drug NameProject B5(Jw Pharmaceutical Corp)
Drug Alias NameImmunological disorder therapeutic(Jw Pharmaceutical Corp)Project B5(Jw Pharmaceutical Corp)
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesC&C Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesJw Pharmaceutical Corp
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A